Advancements in AI-driven diagnostics could transform cardiology, enabling autonomous interpretation of up to 80% of cardiac imaging within a decade. David Ouyang, MD, discusses overcoming barriers to running…
NEW YORK (Reuters Health) – There is no need to avoid proton pump inhibitors (PPIs) in patients on the platelet inhibitors clopidogrel or ticagrelor. The increased rates of…
NEW YORK (Reuters Health) – Data from the German drug-eluting stent (DES.DE) Registry provide no evidence of the “obesity paradox” in the setting of percutaneous coronary intervention (PCI)…
NEW YORK (Reuters Health) – Giving statins before a surgery lowers the risk of heart attack in statin-naïve patients, according to a new meta-analysis. The drugs also reduced…
NEW YORK (Reuters Health) – Systematic collection of extensive family history can improve the risk assessment of cardiovascular disease in primary care, according to a report in the…
NEW YORK (Reuters Health) – Newer generation everolimus-eluting stents (EES) are significantly less likely to prompt very late stent thrombosis than are the first generation of drug-eluting stents…
NEW YORK (Reuters Health) – The everolimus-eluting stent and the sirolimus-eluting stent are equally safe and efficacious in patients with coronary artery disease, the SORT OUT IV Trial…
NEW YORK (Reuters Health) – Long-term clinical outcomes of percutaneous intervention of complex coronary bifurcation lesions are significantly better when the procedure is performed with adjunctive intravascular ultrasound…
NEW YORK (Reuters Health) – Intracoronary artery infusion of autologous stem cells after primary PCI or thrombolysis for acute myocardial infarction improves left ventricular ejection fraction and left…
NEW YORK (Reuters Health) – In patients with heart failure requiring cardiac resynchronization therapy and coexistent atrial fibrillation, AV nodal ablation (AVNA) reduces mortality and improves NYHA functional…
NEW YORK (Reuters Health) – In the PRIMO trial, treatment with vitamin D2 (paricalcitol) did not improve measures of cardiac structure, function or left ventricular mass in patients…
